期刊文献+

Aβ聚集的影响因素和Aβ寡聚体的生理功能 被引量:5

下载PDF
导出
摘要 阿尔茨海默病(AD)俗称老年痴呆症,分为家族型AD和年龄依赖型AD,以后者为主,主要发病年龄在60~65岁以上。我国具有庞大的人口基数,随着老龄化社会的到来,明确AD的生理病理机制变化越来越重要。多年的研究表明大脑内的淀粉样β肽(Aβ)在AD的发生发展中起重要作用。
作者 陈林丽 徐丽
出处 《中国老年学杂志》 CAS CSCD 北大核心 2012年第17期3848-3850,共3页 Chinese Journal of Gerontology
基金 高等学校博士学科点专项科研基金(200801411128) 中央高校基本科研业务费专项基金(DUT10LK32) 青年科学基金项目(31100612)
  • 相关文献

参考文献32

  • 1Glabe CG.Common mechanisms of amyloid oligomer pathogenesis in de-generative disease[J].Neurobiol Aging,2006;27(4):570-5.
  • 2Petkova AT,Ishii Y,Balbach JJ,et al.A structural model for Alzheimer'sβ-amyloid fibrils based on experimental constraints from solid state NMR[J].Proc Natl Acad Sci USA,2002;99(26):16742-7.
  • 3Liu RT,McAllister C,Lyubchenko Y,et al.Residues 17-20 and 30-35 ofbeta-amyloid play critical roles in aggregation[J].J Neurosci Res,2004;75(12):162-71.
  • 4Liu G,Prabhakar A,Aucoin D,et al.Mechanistic studies of peptide self-assembly:transientα-helices to stableβ-sheets[J].J Am Chem Soc,2010;132(51):18223-32.
  • 5Yan Y,Wang C.Aβ42 is more rigid than Aβ40 at the C terminus:implica-tions for Aβaggregation and toxicity[J].Mol Biol,2006;364(5):853-62.
  • 6Taniguchi A,Sohma Y,Hirayama Y,et al.“Click Peptide”:pH-triggeredin situ production and aggregation of monomer Aβ1-42[J].Chembio-chem,2009;10(4)710-5.
  • 7Gouras GK,Almeida CG,Takahashi RH.Intraneuronal Aβaccumulationand origin of plaques in Alzheimer's disease[J].Neurobiol Aging,2005;26(9):1235-44.
  • 8Bush AL.The metallobiology of Alzheimer's disease[J].Trends Neuros-ci,2003;26(4):207-14.
  • 9Zatta P,Drago D,Bolognin S,et al.Alzheimer's disease,metal ions andmetal homeostatic therapy[J].Trends Pharmacol Sci,2009;30(7):346-55.
  • 10Isaacs AM,Senn DB,Yuan M,et al.Acceleration of amyloid-peptide ag-gregation by physiological concentrations of calcium[J].JBC,2006;281(38):27916-23.

同被引文献67

  • 1李春艳.中国阿尔茨海默病流行病学现状及三级预防对策研究[J].实用老年医学,2013,27(7):604-606. 被引量:20
  • 2王玉香,曾爱源,李清华.β-淀粉样蛋白在阿尔茨海默病中的作用研究进展[J].中国老年学杂志,2014,34(12):3495-3497. 被引量:7
  • 3罗磊,杜艳军,孙国杰.Aβ1~40、Aβ1~42与Aβ25~35在阿尔茨海默病模型复制中的评价[J].中国老年学杂志,2014,34(9):2584-2586. 被引量:14
  • 4Boeve BF. Mild cognitive impairment asso- ciated with underlying Alzheimer's disease versus Lewy body disease [J]. Parkinsonism Relat Dis- ord, 2012, 18: $41-$44.
  • 5Serrano-Pozo A, Frosch MP, Masliah E, et al. Neuropathological alterations in Alzheimer dis- ease[J]. Cold Spring Harb Perspect Med, 2011, 1: a006189.
  • 6Small SA, Gandy S. Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis [J]. Neuron, 2006, 52: 15-31.
  • 7Hatters DM, Griffin MD. Diagnostics for amyloid fibril formation: where to begin [J]? Methods Mol Biol, 2011,752: 121-136.
  • 8Glenner GG, Wong CW. Alzheimer's dis- ease: initial report of the purification and charac- terization of a novel cerebrovascular amyloid protein [J]. Biochem Biophys Res Commun, 1984, 120: 885-890.
  • 9Masters CL, Simms G, Weinman NA, et al. Amyloid plaque core protein in Alzheimer dis- ease and Down syndrome[J]. Proc Natl Acad Sci USA, 1985, 82: 4245-4249.
  • 10Hardy JA, Higgins GA. Alzheimer's disease: the arnyloid cascade hypothesis[J]. Science, 1992, 256: 184-185.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部